Blood Cancer UK

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 170 papers

  • Open Access
  • Research Article

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia

  • Jan 01, 2026
  • Cell Reports Medicine
  • Diego A Pereira-Martins +17
  • Open Access
  • Research Article

Identification of predictive protein signatures of treatment-free remission in patients with chronic myeloid leukaemia

  • Nov 03, 2025
  • Blood
  • Isla Nosratzadeh +8
  • Open Access
  • Research Article
  • Citations2

Evaluation of current mouse in vivo models and advanced in vitro models for leukaemia research.

  • Jun 01, 2025
  • Blood reviews
  • Xenia Bubnova +2
  • Open Access
  • PDF
  • Research Article
  • Citations6

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes

  • Apr 09, 2025
  • Leukemia
  • Fadimana Kaya +36
  • Open Access
  • PDF
  • Research Article
  • Citations4

ARID1A mutations protect follicular lymphoma from FAS-dependent immune surveillance by reducing RUNX3/ETS1-driven FAS-expression

  • Jan 23, 2025
  • Cell Death & Differentiation
  • Martina Antoniolli +24
  • Open Access
  • Preprint Article

Disparities in Blood Cancer Survival in the UK 2009-2019: National Cohort Studies

  • Jan 01, 2025
  • SSRN Electronic Journal
  • Janice Hoang +10
  • Abstract

Plinabulin and Selumetinib Enhance M1 Macrophage Traits and Trigger Cell Death in AML

  • Nov 05, 2024
  • Blood
  • Lucio Henrique Pinheiro +9
  • Open Access
  • Research Article
  • Citations16

Multifaceted neuroprotective approach of Trolox in Alzheimer's disease mouse model: targeting Aβ pathology, neuroinflammation, oxidative stress, and synaptic dysfunction

  • Sep 17, 2024
  • Frontiers in Cellular Neuroscience
  • Muhammad Tahir +6
  • Open Access
  • Supplementary Content
  • Citations6

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)

  • May 01, 2024
  • HemaSphere
  • Fabio Efficace +27
  • Open Access
  • Research Article
  • Citations1

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

  • Dec 20, 2023
  • European Journal of Haematology
  • Clement Twumasi +22
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.